These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1957 related articles for article (PubMed ID: 15472075)

  • 1. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.
    Weng AP; Ferrando AA; Lee W; Morris JP; Silverman LB; Sanchez-Irizarry C; Blacklow SC; Look AT; Aster JC
    Science; 2004 Oct; 306(5694):269-71. PubMed ID: 15472075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling.
    Pear WS; Aster JC
    Curr Opin Hematol; 2004 Nov; 11(6):426-33. PubMed ID: 15548998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NOTCH1 pathway: a molecular target in T-cell cancers?
    Holowiecki J
    Lancet; 2005 Jan 15-21; 365(9455):197-9. PubMed ID: 15652588
    [No Abstract]   [Full Text] [Related]  

  • 4. Leukemia-associated mutations within the NOTCH1 heterodimerization domain fall into at least two distinct mechanistic classes.
    Malecki MJ; Sanchez-Irizarry C; Mitchell JL; Histen G; Xu ML; Aster JC; Blacklow SC
    Mol Cell Biol; 2006 Jun; 26(12):4642-51. PubMed ID: 16738328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kick it up a Notch: NOTCH1 activation in T-ALL.
    Gridley T
    Cancer Cell; 2004 Nov; 6(5):431-2. PubMed ID: 15542425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of the Notch1 gene in T-cell acute lymphoblastic leukemia: analysis in adults and children.
    Lee SY; Kumano K; Masuda S; Hangaishi A; Takita J; Nakazaki K; Kurokawa M; Hayashi Y; Ogawa S; Chiba S
    Leukemia; 2005 Oct; 19(10):1841-3. PubMed ID: 16079893
    [No Abstract]   [Full Text] [Related]  

  • 8. Activating Notch1 mutations in mouse models of T-ALL.
    O'Neil J; Calvo J; McKenna K; Krishnamoorthy V; Aster JC; Bassing CH; Alt FW; Kelliher M; Look AT
    Blood; 2006 Jan; 107(2):781-5. PubMed ID: 16166587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to gamma-secretase inhibitors.
    Palomero T; Barnes KC; Real PJ; Glade Bender JL; Sulis ML; Murty VV; Colovai AI; Balbin M; Ferrando AA
    Leukemia; 2006 Jul; 20(7):1279-87. PubMed ID: 16688224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
    De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
    Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOTCH1 mutations in T-cell acute lymphoblastic leukemia: prognostic significance and implication in multifactorial leukemogenesis.
    Zhu YM; Zhao WL; Fu JF; Shi JY; Pan Q; Hu J; Gao XD; Chen B; Li JM; Xiong SM; Gu LJ; Tang JY; Liang H; Jiang H; Xue YQ; Shen ZX; Chen Z; Chen SJ
    Clin Cancer Res; 2006 May; 12(10):3043-9. PubMed ID: 16707600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia.
    Pancewicz J; Taylor JM; Datta A; Baydoun HH; Waldmann TA; Hermine O; Nicot C
    Proc Natl Acad Sci U S A; 2010 Sep; 107(38):16619-24. PubMed ID: 20823234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling.
    Malyukova A; Dohda T; von der Lehr N; Akhoondi S; Corcoran M; Heyman M; Spruck C; Grandér D; Lendahl U; Sangfelt O
    Cancer Res; 2007 Jun; 67(12):5611-6. PubMed ID: 17575125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOTCH1 extracellular juxtamembrane expansion mutations in T-ALL.
    Sulis ML; Williams O; Palomero T; Tosello V; Pallikuppam S; Real PJ; Barnes K; Zuurbier L; Meijerink JP; Ferrando AA
    Blood; 2008 Aug; 112(3):733-40. PubMed ID: 18411416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive Langerhans cell histiocytosis following T-ALL: clonally related neoplasms with persistent expression of constitutively active NOTCH1.
    Rodig SJ; Payne EG; Degar BA; Rollins B; Feldman AL; Jaffe ES; Androkites A; Silverman LB; Longtine JA; Kutok JL; Fleming MD; Aster JC
    Am J Hematol; 2008 Feb; 83(2):116-21. PubMed ID: 17874453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
    Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
    Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cells.
    Rao SS; O'Neil J; Liberator CD; Hardwick JS; Dai X; Zhang T; Tyminski E; Yuan J; Kohl NE; Richon VM; Van der Ploeg LH; Carroll PM; Draetta GF; Look AT; Strack PR; Winter CG
    Cancer Res; 2009 Apr; 69(7):3060-8. PubMed ID: 19318552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting promiscuous signaling pathways in cancer: another Notch in the bedpost.
    Beverly LJ; Capobianco AJ
    Trends Mol Med; 2004 Dec; 10(12):591-8. PubMed ID: 15567329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OLIG2 (BHLHB1), a bHLH transcription factor, contributes to leukemogenesis in concert with LMO1.
    Lin YW; Deveney R; Barbara M; Iscove NN; Nimer SD; Slape C; Aplan PD
    Cancer Res; 2005 Aug; 65(16):7151-8. PubMed ID: 16103065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An activating intragenic deletion in NOTCH1 in human T-ALL.
    Haydu JE; De Keersmaecker K; Duff MK; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Ferrando A
    Blood; 2012 May; 119(22):5211-4. PubMed ID: 22510873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 98.